Candel Therapeutics, Inc.

CADL · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$102,654$35,413$70,058$82,642
Short-Term Investments$0$0$0$0
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$1,150$1,384$1,887$2,303
Total Curr. Assets$103,804$36,797$71,945$84,945
Property Plant & Equip (Net)$2,733$4,022$5,480$3,836
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$266$424
Tax Assets$0$0$828$0
Other NC Assets$329$382$0$0
Total NC Assets$3,062$4,404$6,574$4,260
Other Assets$0$0$0$0
Total Assets$106,866$41,201$78,519$89,205
Liabilities
Payables$237$422$380$1,590
Short-Term Debt$10,461$9,406$464$0
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$26,831$4,356$4,771$3,772
Total Curr. Liab.$37,529$14,184$5,615$5,362
LT Debt$3,010$13,356$22,336$560
Deferred Rev, NC$0$0$144$0
Deferred Tax Liab, NC$0$0$828$0
Other NC Liab.$0$916$1,882$19,146
Total NC Liab.$3,010$14,272$25,190$19,706
Other Liabilities$0$0$0$0
Cap. Leases$973$1,486$1,486$0
Total Liabilities$40,539$28,456$30,805$25,068
Equity
Pref Stock$0$0$0$89,205
Common Stock$469$290$290$286
Retained Earnings-$192,205-$137,028-$99,089-$80,295
AOCI-$0$0$0-$89,205
Other Equity$258,063$149,483$146,513$144,146
Total Equity$66,327$12,745$47,714$64,137
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$106,866$41,201$78,519$89,205
Net Debt-$89,183-$12,651-$47,258-$82,082